Undernutrition in children aged 0-59 months by region and over time: secondary analysis of the Burkina Faso 2012-2018 National Nutrition Surveys.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
06 09 2023
Historique:
medline: 8 9 2023
pubmed: 7 9 2023
entrez: 6 9 2023
Statut: epublish

Résumé

The global burden of undernutrition remains high, responsible for significant under-five mortality in resource-limited settings. Numerous sustainable development goals (SDGs) are linked to nutrition, and nationally representative nutrition surveillance is a key activity to track progress towards SDGs and guide efficient programmes. The aim of this study is to look at spatial and temporal trends in undernutrition in children under 5 years age in Burkina Faso. We used data from annual National Nutrition Surveys using Standardised Monitoring and Assessment of Relief and Transitions methodology (anthropometry, morbidity) over 7 years (2012-2018) in Burkina Faso. Children of under 5 years from households selected through systemic sampling at countrywide level. Prevalence of stunting (height-for-age z-score, <-2), underweight (weight-for-age z-score, <-2) and wasting (weight-for-height z-score, <-2) at regional and national. We used general linear mixed models, adjusted by age, survey year, sex, presence of fever and/or diarrhoea, and poverty index to quantify the risk of undernutrition over time and by region of residence. Between 2012 and 2018, decreases were observed overall in the prevalence of growth retardation (stunting) decreased from 33.0% (95% CI 32.3 to 33.8) in 2012 to 26.7% (95% CI 26.2 to 27.3) in 2018. Underweight reduced from 24.4% (95% CI 23.7 to 25.1) to 18.7% (95% CI 18.2 to 19.2) for the same period and wasting decreased from 10.8% (95% CI 10.3 to 11.3) in 2012 to 8.4% (95% CI 8.1 to 8.8) in 2018. However, there was substantial variation across the country, with increased risk of undernutrition in the regions of Sahel, East and Cascades primarily. High-risk regions were characterised by a lower poverty index and limited access to healthcare services. Our findings could inform national policymakers in refining and optimising resource allocation based on the identification of high-risk areas.

Identifiants

pubmed: 37673454
pii: bmjopen-2022-066509
doi: 10.1136/bmjopen-2022-066509
pmc: PMC10496659
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e066509

Subventions

Organisme : Department of Health
ID : 17/63/154
Pays : United Kingdom

Investigateurs

Abraham Oduro (A)
Cornelius Debpuur (C)
Doreen Ayibisah (D)
Edith Dambayi (E)
Engelbert Nonterah (E)
Esmond W Nonterah (EW)
James Adoctor (J)
Josephine Addi (J)
Maxwell Dalaba (M)
Michael Banseh (M)
Paul Welaga (P)
Paula Beeri (P)
Samuel Chatio (S)
Winfred Ofosu (W)
Adélaïde Compaoré (A)
Aminata Welgo (A)
Kadija Ouedraogo (K)
Karim Derra (K)
Caroline Fall (C)
Keith Godfrey (K)
Mark Hanson (M)
Mary Barker (M)
Polly Hardy-Johnson (P)
Sarah Kehoe (S)
Marie-Louise Newell (ML)
Daniella Watson (D)
Shane A Norris (SA)
Stephanie Wrottesley (S)

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Am J Public Health. 1993 Aug;83(8):1130-3
pubmed: 8342721
Am J Clin Nutr. 2013 Apr;97(4):896-901
pubmed: 23426036
Lancet. 2008 Jan 19;371(9608):243-60
pubmed: 18207566
Lancet. 2013 Aug 3;382(9890):427-451
pubmed: 23746772
Arch Public Health. 2018 Jul 16;76:28
pubmed: 30026945
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33328202
Public Health Nutr. 2018 Nov;21(16):2915-2928
pubmed: 30156173
Nutrients. 2020 Aug 12;12(8):
pubmed: 32806622
Lancet. 2008 Feb 16;371(9612):588-95
pubmed: 18280329
Public Health Nutr. 2012 Jan;15(1):142-8
pubmed: 21752311
BMJ Open. 2019 Sep 30;9(9):e029968
pubmed: 31570408
BMC Pediatr. 2017 Jan 13;17(1):15
pubmed: 28086835
Matern Child Nutr. 2018 Apr;14(2):e12516
pubmed: 28944990
Public Health Nutr. 2012 Sep;15(9):1715-27
pubmed: 22694984
Public Health Nutr. 2017 Jun;20(9):1627-1639
pubmed: 28367794
BMJ Glob Health. 2016 Jul 7;1(1):e000056
pubmed: 28588927
Arch Public Health. 2017 Jul 10;75:29
pubmed: 28694966
Public Health Nutr. 2009 Nov;12(11):1974-82
pubmed: 19254427
World Rev Nutr Diet. 2015;113:139-46
pubmed: 25906873
Trials. 2017 Sep 6;18(1):412
pubmed: 28874177
PLOS Glob Public Health. 2023 Mar 29;3(3):e0001737
pubmed: 36989221
Int J Equity Health. 2020 Aug 25;19(1):143
pubmed: 32843046

Auteurs

Palwende Romuald Boua (PR)

Clinical Research Unit of Nanoro, Institut de Recherche en Sciences de la Sante, Nanoro, Burkina Faso romyboua@gmail.com.
Sydney Brenner Institute for Molecular Biosciences, University of the Witwatersrand Johannesburg, Johannesburg, South Africa.

Toussaint Rouamba (T)

Clinical Research Unit of Nanoro, Institut de Recherche en Sciences de la Sante, Nanoro, Burkina Faso.

Estelle Bambara (E)

Direction de la Nutrition, Ministère de la Santé, Ouagadougou, Burkina Faso.

Saidou Kaboré (S)

Direction de la Nutrition, Ministère de la Santé, Ouagadougou, Burkina Faso.

Ella W R Compaore (EWR)

Laboratoire de Biochimie, Biotechnologie, Technologie Alimentaire et Nutrition (LABIOTAN), Université Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.

Boureima Ouedraogo (B)

Institut National de Statistique et de la Démographie, Ouagadougou, Burkina Faso.

Halidou Tinto (H)

Clinical Research Unit of Nanoro, Institut de Recherche en Sciences de la Sante, Nanoro, Burkina Faso.

Marie-Louise Newell (ML)

MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.

Kate Ward (K)

MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
Global Health Research Institute, University of Southampton, Southampton, UK.

Hermann Sorgho (H)

Clinical Research Unit of Nanoro, Institut de Recherche en Sciences de la Sante, Nanoro, Burkina Faso.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH